Login to Your Account



Financings Roundup

SpePharm Raises €26M to Spur Further Growth

By Staff Reports


Friday, August 22, 2008

No Abstract

SpePharm Holding BV closed on a €16 million (US$23.8 million) equity financing round to fund ongoing growth and entered into a €10 million revenue interest acquisition financing agreement related to its purchase of Dantrium for Europe and other markets from Procter & Gamble Pharmaceuticals, a division of P&G, of Cincinnati.

The special pharma company and JHP Pharmaceuticals LLC recently closed on their purchase of Dantrium (Dantrolene Sodium).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription